Kalimantacin A, B, and C, Novel Antibiotics Produced by Alcaligenes sp. YL-02632S II. Physico-chemical Properties and Structure Elucidation
スポンサーリンク
概要
- 論文の詳細を見る
- 1996-02-25
著者
-
TOKUNAGA Tatsuhiro
Chemical Analysis Center, Chiba University
-
TOKUNAGA Tatsuhiro
Molecular Chemistry Research Lab. Yamanoushi Pharmaceutical Co. Ltd
-
Tokunaga Tatsuhiro
Molecular Chemistry Resarch Laboratories Institute For Drug Discovery Research Yamanouchi Pharmaceut
-
Tokunaga Tatsuhiro
Molecular Chemistry Research Lab. Yamanouchi Pharmaceutical Co. Ltd.
-
Tokunaga Tatsuhiro
Chemical Analysis Center Chiba University
-
Tokunaga Tatsuhiro
Analysis & Metabolism Laboratories Institute For Drug Discovery Research Yamanouchi Pharmaceutic
-
Shibazaki Mitsuyoshi
Microbiology Laboratories Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Shibazaki Mitsuyoshi
Microbology Research Dept. Drug Serendipity Research Labs. Yamanouchi Pharmaceutical Co. Ltd
-
ORITA Masaya
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
Shimizu Minoru
Molecular Chemistry Research Lab. Yamanouchi Pharmaceutical Co. Ltd.
-
Orita Masaya
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
KAMIGIRI Kazuma
Drug Serendipity Research Lab., Yamanouchi Pharmaceutical Co., Ltd.
-
ORITA Masaya
Molecular Chemistry Research Lab., Yamanouchi Pharmaceutical Co., Ltd.
-
NISHIKAWA Toshiaki
Analytical Science Reserch Lab., Yamanouchi Pharmaceutical Co., Ltd.
-
Kamigiri Kazuma
Drug Serendipity Research Lab. Yamanouchi Pharmaceutical Co. Ltd.
-
Shimizu Masaki
Division Of Microbial Chemistry Faculty Of Pharmaceutical Sciences Chiba University
-
Nishikawa Toshiaki
Analytical Science Reserch Lab. Yamanouchi Pharmaceutical Co. Ltd.
関連論文
- NO吸入療法を施行した新生児遷延性肺高血圧症の神経学的予後
- サーファクタント導入後の在胎23-24週で院外出生した児の生存予測因子
- Morbidity and mortality of infants born at the threshold of viability : Ten years' experience in a single neonatal intensive care unit, 1991-2000
- アルブミン療法を受けた高アンバンドビリルビ血症の児の聴性脳幹反応の推移
- Preventive management of hypoglycemia in very low-birthweight infants following indomethacin therapy for patent ductus arteriosus
- A newborn infant with lipoprotein glomerulopathy associated with congenital nephrotic syndrome
- Effects of albumin infusion therapy on total and unbound bilirubin values in term infants with intensive phototherapy
- Intractable hypoglycemia following indomethacin therapy for patent ductus arteriosus
- YM-92447 (Spinosulfate A), a Neuraminidase Inhibitor Produced by an Unidentified Pycnidial Fungus
- YM-215343, a Novel Antifungal Compound from Phoma sp. QN04621
- Microbial Glycosylation and Acetylation of Brefeldin A
- Quinolactacins A, B and C : Novel Quinolone Compounds from Penicillium sp. EPF-6 II. Physico-chemical Properties and Structure Elucidation
- Reduction in blood glucose values following indomethacin therapy for patent ductus arteriosus
- A New Broad Band Probe Covering from ^P-to^Cl-Nuclear Magnetic Resonance
- PFG J-HMBC 2D NMR Spectroscopic Observation of the Natural Abundance ^1H-^N Long-Range Coupling
- YM-32890 A and B, New Types of Macrolide Antibiotis Produced by Cytophaga sp.
- YM-47522, a Novel Antifungal Antibiotic Produced by Bacillus sp-II. Structure and Relative Stereochemistry
- Anti-obesity and Anti-diabetic Activities of a New β_3 Adrenergic Receptor Agonist, (S)-(Z)-[4-[[1-[2-[(2-Hydroxy-3-phenoxypropyl)]amino]athyl]-1-propenyl]phenoxy] Acetic Acid Ethanedioic Acid (SWR-0342SA), in KK-A^y Mice
- Synthesis and Structure-Activity Relationships in a Series of Ethenesulfonamide Derivatives, a Novel Class of Endothelin Receptor Antagonists
- Spiro-Substituted Piperidines as Neurokinin Receptor Antagonists. III. Synthesis of (±)-N-[2-(3,4-Dichlorophenyl)-4-(spiro-substituted piperidin-1'-yl)butyl]-N-methylbenzamides and Evaluation of NK_1-NK_2 Dual Antagonistic Activities
- cAMP-Independent Chloride Secretion Activated by a Vasoactive Intestinal Peptide in a Monolayer Culture of Human Bronchinal Epithelial Cells
- YM-47522, a Novel Antifungal Antibiotic Produced by Bacillus sp-I. Taxonomy, Fermentation, Isolation and Biological Properties
- Novel 5-Hydroxytryptamine (5-HT_3) Receptor Antagonists. IV. Synthesis and Pharmacological Evaluation of the Oxidation Products of (-)-(R)-5-[(1-Methyl-1H-indol-3-yl)carbonyl]-4,5,6,7-tetrahydro-1H-benzimidazole Hydrochloride (YM060 : Ramosetron)
- Novel 5-Hydroxytryptamine (5-HT_3) Receptor Antagonists. III. Pharmacological Evaluations and Molecular Modeling Studies of Optically Active 4,5,6,7-Tetrahydro-1H-benzimidazole Derivatives
- Kalimantacin A, B, and C, Novel Antibiotics Produced by Alcaligenes sp. YL-02632S II. Physico-chemical Properties and Structure Elucidation
- YM-47141 and YM-47142, New Elastase Inhibitors Produced by Flexibacter sp.Q17897 II.Structure Elucidation
- YM-47141 and 47142, New Elastase Inhibitors Produced by Flexibacter sp.Q17897 I.Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
- YM-30059, a Novel Quinolone Antibiotic Produced by Arthrobacter sp.
- Kalimantacins A, Band C, Novel Antibiotics from Alcaligenes sp. YL-02632S I. Taxonomy, Fermentation, Isolation and Biological Properties
- Paroxysmal kinesigenic choreoathetosis associated with prenatal brain damage
- Fosfomycin Resistance in Escherichia coli in Japan
- Sudden death due to dissecting aortic aneurysm in and adolescent without any underlying disease